Praxsyn Profit Margin

The latest profit margin for PXYN is 13.09% as of September 2019. That compares with 6.66% in the prior-year period — up 96.5% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Praxsyn's historical trend and sector peers before judging valuation or financial health.

Over the past year, PXYN's profit margin moved from 6.66% to 13.09% — a 96.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Praxsyn's valuation or profitability profile.

Against Healthcare companies, PXYN currently prints 13.09% for profit margin, while the sector average sits near 19.13%. That is roughly 31.6% below the sector mean. Large gaps often invite a closer look at Praxsyn's growth, margins, and balance sheet.

Profit Margin shows how effectively Praxsyn converts resources into returns. At 13.09%, PXYN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 6.66% in the prior-year period — up 96.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PXYN's profit margin (13.09%), review year-over-year change from 6.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.